ArticleThe Journal of pathology2023

Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition.

Vignesh Sundararajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.